News Coverage 04.23.21 Share on Twitter Share on Facebook Share on LinkedIn Tumor-infiltrating lymphocytes show ‘provocative’ response rates in advanced melanoma Related Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment Announcement, Press Release Dr. Sager Named Recipient of PICI’s Inaugural YIA Award